MEI Pharma Stock Forecast, Price & News

MEI Pharma (NASDAQ:MEIP) Frequently Asked Questions

Is MEI Pharma a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MEI Pharma in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MEI Pharma stock.
View analyst ratings for MEI Pharma or view top-rated stocks.

How has MEI Pharma's stock price been impacted by Coronavirus?

MEI Pharma's stock was trading at $1.55 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MEIP stock has increased by 44.5% and is now trading at $2.24.
View which stocks have been most impacted by COVID-19.

Are investors shorting MEI Pharma?

MEI Pharma saw a decline in short interest in the month of December. As of December 15th, there was short interest totaling 6,990,000 shares, a decline of 20.1% from the November 30th total of 8,750,000 shares. Based on an average daily trading volume, of 1,470,000 shares, the days-to-cover ratio is presently 4.8 days. Approximately 6.5% of the company's stock are sold short.
View MEI Pharma's Short Interest.

When is MEI Pharma's next earnings date?

MEI Pharma is scheduled to release its next quarterly earnings announcement on Thursday, February 3rd 2022.
View our earnings forecast for MEI Pharma.

How were MEI Pharma's earnings last quarter?

MEI Pharma, Inc. (NASDAQ:MEIP) released its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.13) earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of ($0.13). The business had revenue of $13.39 million for the quarter, compared to analysts' expectations of $9.98 million. MEI Pharma had a negative net margin of 172.03% and a negative trailing twelve-month return on equity of 100.10%.
View MEI Pharma's earnings history.

What price target have analysts set for MEIP?

4 analysts have issued 12 month price objectives for MEI Pharma's shares. Their forecasts range from $8.00 to $20.00. On average, they anticipate MEI Pharma's share price to reach $11.75 in the next year. This suggests a possible upside of 424.6% from the stock's current price.
View analysts' price targets for MEI Pharma or view top-rated stocks among Wall Street analysts.

Who are MEI Pharma's key executives?

MEI Pharma's management team includes the following people:

• Daniel P. Gold, President, Chief Executive Officer & Director
• David M. Urso, Chief Operating Officer & General Counsel
• Brian G. Drazba, Chief Financial Officer & Secretary
• Richard G. Ghalie, Chief Medical Officer
• Tina C. Beamon, Chief Compliance Officer

Who are some of MEI Pharma's key competitors?

Some companies that are related to MEI Pharma include Merus (MRUS), Vaxxinity (VAXX), MorphoSys (MOR), PureTech Health (PRTC), Reata Pharmaceuticals (RETA), Revance Therapeutics (RVNC), Organogenesis (ORGO), Axsome Therapeutics (AXSM), BELLUS Health (BLUSF), Rani Therapeutics (RANI), Day One Biopharmaceuticals (DAWN), MannKind (MNKD), AnaptysBio (ANAB), Heron Therapeutics (HRTX) and Crinetics Pharmaceuticals (CRNX).
View all of MEIP's competitors.

What other stocks do shareholders of MEI Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MEI Pharma investors own include Inovio Pharmaceuticals (INO), Rigel Pharmaceuticals (RIGL), Gilead Sciences (GILD), Novavax (NVAX), Dynavax Technologies (DVAX), SCYNEXIS (SCYX), OPKO Health (OPK), VBI Vaccines (VBIV), Sorrento Therapeutics (SRNE) and TherapeuticsMD (TXMD).

What is MEI Pharma's stock symbol?

MEI Pharma trades on the NASDAQ under the ticker symbol "MEIP."

How do I buy shares of MEI Pharma?

Shares of MEIP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MEI Pharma's stock price today?

One share of MEIP stock can currently be purchased for approximately $2.24.

How much money does MEI Pharma make?

MEI Pharma has a market capitalization of $252.50 million and generates $25.53 million in revenue each year. The company earns $-50.58 million in net income (profit) each year or ($0.66) on an earnings per share basis.

How many employees does MEI Pharma have?

MEI Pharma employs 51 workers across the globe.

What is MEI Pharma's official website?

The official website for MEI Pharma is www.meipharma.com.

Where are MEI Pharma's headquarters?

MEI Pharma is headquartered at 11455 EL CAMINO REAL SUITE 250, SAN DIEGO CA, 92130.

How can I contact MEI Pharma?

MEI Pharma's mailing address is 11455 EL CAMINO REAL SUITE 250, SAN DIEGO CA, 92130. The company can be reached via phone at (858) 369-7100, via email at [email protected], or via fax at 302-655-5049.